Lacosamide Tablet, Film Coated
Product Images NDC 31722-815

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 31722-815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lacosamide-fig1 (Lacosamide Fig1)

FDA Label Image

Lacosamide-fig2 (Lacosamide Fig2)

This appears to be a graph showing the responder rate of different medications (a placebo, and three dosages of Lacosamide) in treating an unknown condition. The responder rate is measured in percentages and it appears that the highest dosage of Lacosamide (600 mg/day) has the highest responder rate at around 70-75%, while the other dosages and the placebo have lower rates. The graph also shows a negative percentage for the placebo, which is not possible. Overall, without more context or information on the condition being treated, the data is not very useful.*

FDA Label Image

Lacosamide-fig4 (Lacosamide Fig4)

GAMBEK is a medication containing lacosamide in the form of tablets, with each tablet containing 50 mg of the active ingredient. It is a prescription medicine, and the pharmacist should provide a medication guide to each patient. The usual dosage can be found in the package insert. It should be stored at a temperature of 20° to 25°C and kept out of reach of children. The medication is manufactured by Annora Pharma Pyt Ltd in India and is marketed by Camber Pharmaceuticals in the US. The batch code for the medication is 2101633.*

FDA Label Image

Lacosamide-fig5 (Lacosamide Fig5)

FDA Label Image

Lacosamide-fig6 (Lacosamide Fig6)

This is a description of a medication called Lacosamide. It comes in tablet form, and each film-coated tablet contains 150 mg of Lacosamide, USP. The medication guide provided separately to each patient should be dispensed by the pharmacist. The usual dosage can be found in the package insert provided. The medication needs to be stored between 20° to 25°C (68° to 77°F) and should be kept out of reach of children. Further information about the medication can be found on the manufacturer's website or by calling the U.S. contact number provided. The medication is made by Annora Pharma Pvt. Ltd., Sangareddy, India, and is manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ.*

FDA Label Image

Lacosamide-fig7 (Lacosamide Fig7)

This is a prescription drug called Lacosamide manufactured by Annora Pharma Pt. Ltd in Telangana, India, for Camber Pharmaceuticals, Inc in NJ, USA. The drug comes in the form of 200 mg tablets and is meant to be kept out of reach of children. The package insert contains full prescribing information and the medication guide is available at camberpharma.com. There is a batch coding area on the package.*

FDA Label Image

Lacosamide-logo1 (Lacosamide Logo1)

FDA Label Image

Lacosamide-logo2 (Lacosamide Logo2)

FDA Label Image

Chemical Structure (Lacosamide Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.